Table 2.
IMiD-based regimen | 15 (29) |
PI-based regimen | 15 (29) |
IMiD + PI-based regimen | 16 (31) |
Conventional chemotherapy | 2 (4) |
No induction treatment | 3 (6) |
Maintenance therapy after auto-HCT | 16 (31) |
IMiD, immunomodulatory drugs (lenalidomide or thalidomide); PI, proteasome inhibitors; auto-HCT, autologous hematopoietic stem cell transplant; conventional, alkylating agent or steroid based therapy.